P9C-19734-36052
5 vaccinations
4 coded responses
53 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Registered in v-safe
-
2021-03-20
Dose 1 — Moderna
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-03
- 2021-04-10
-
2021-04-17
Dose 2 — Moderna
- 2021-04-17
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-07-17
- 2021-10-16
-
2021-11-01
Dose 3 — Pfizer-BioNTech
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2022-01-31
Survey response — 3 months, dose 3MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Dose 4 — Pfizer-BioNTech
- 2022-05-02
-
2022-09-18
Dose 5 — Pfizer-BioNTech
-
2022-09-18
Health check-in — day 0, dose 5Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-19
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-20
Survey response — days 1–6 daily, dose 5MedDRA: Nipple pain — Feeling: GoodFree text: Nipple painMedDRA releases: 2024-11 · check-in free text available
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
-
2022-10-02
Survey response — day 14, dose 5MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-10-30
- 2022-12-18
- 2023-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Moderna | |
| 2 | 2021-04-17 | Moderna | |
| 3 | 2021-11-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-18 | Pfizer-BioNTech | No |
| 5 | 2022-09-18 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Chest pain
Release 11 — 3 months, dose 3
Symptoms: Headache
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Nipple pain
Release 12 — day 14, dose 5
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Nipple pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release